Supreme Court Ruling: Healthcare Leader Response
The Supreme Court has ruled in favor of the ACA, ensuring millions maintain access to critical preventive care coverage. This landmark decision preserves services such as cancer screenings and STD testing, directly impacting healthcare access nationwide. The ruling addressed challenges concerning the U.S. Preventive Services Task Force, with Justice Kavanaugh delivering the majority opinion. While the court upheld the ACA mandate, religious freedom concerns persist, notably regarding PrEP.Industry leaders, including the American Cancer Society, have weighed in on the importance of this decision for Americans. News Directory 3 provided insightful coverage of the case’s implications. despite this victory, legal battles continue in lower courts concerning religious exemptions. Discover what’s next for healthcare and the evolving landscape of access.
Supreme Court Upholds ACA Mandate on Preventive Care Coverage
Updated June 29,2025
in a closely watched case,the Supreme Court has ruled in Braidwood Management v. Becerra, upholding the Affordable Care Act’s (ACA) requirement that insurers cover preventive services without cost-sharing. The decision ensures continued access to vital services, including cancer screenings, pregnancy care, and sexually transmitted disease testing, for millions of Americans.
The lawsuit, brought by Texas residents and Christian-affiliated businesses, challenged the constitutionality of the U.S. Preventive Services Task Force’s (USPSTF) appointment process and argued that covering pre-exposure prophylaxis (PrEP) for HIV prevention violated their religious beliefs. They cited the appointments clause and the Religious Freedom Restoration Act (RFRA).
Justice Brett Kavanaugh, writing for the 6-3 majority, stated that USPSTF members are “inferior officers” not requiring Senate approval. He noted that Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has the authority to appoint, dismiss, and review the task force’s recommendations. Justices Clarence Thomas, Samuel Alito, and Neil Gorsuch dissented.
A lower court had previously sided with Braidwood on the religious freedom claim, a point the Supreme Court acknowledged was not appealed by the government. Daniel Frier, a healthcare attorney with Frier Levitt, noted that this aspect of the case remains with the district court.
Lisa lacasse, president of the American Cancer Society Cancer Action Network, applauded the ruling, stating, “Research has shown that any out-of-pocket costs can be a deterrent to accessing proven cancer screening, which can be the difference between life and death.”
Families USA, a consumer advocacy group, estimates the decision provides security to over 170 million Americans by maintaining access to preventive services without cost-sharing. However, Executive Director Anthony Wright expressed concern over the HHS secretary’s power to influence the USPSTF’s recommendations, urging vigilance to prevent actions that could undermine coverage.
Greg Fosheim, a partner at McDermott Will & Emery, emphasized the broader implications, stating, “The decision does not resolve the deeper legal and political uncertainty surrounding health care access.” He cautioned that the ruling, combined with the Court’s decision in United States v. Skrmetti, highlights the vulnerability of essential healthcare services, notably those intersecting with contested social or religious issues. Fosheim also noted the potential for future religious exemptions regarding services like PrEP, suggesting that access to thorough care could still be narrowed.
What’s next
The religious freedom aspect of the case will continue in the lower courts, potentially shaping the scope of religious exemptions under federal healthcare law.The ongoing debate highlights the complex interplay between healthcare access, religious beliefs, and political considerations.